Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Technology
Scientific & Technical Instruments
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United...
States of America.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Oct 31, 2022 10:00am
Market is fickle
Looks like whenever there is an upward momentum in stock price someone uses it to drive the price back down by selling. Regardless of this, IPA is getting closer to going much higher as TATX3 will go
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Oct 26, 2022 3:27pm
New momentum
IPA is building momentum now and latest will help: Get in now is my advise. IPA's Subsidiary Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net
posted May 02, 2024 9:00am by
Xcyte Digital Corp.
-
|
"The addition of Webinar.net further enhances Xcyte's suite of solutions by adding a technology platform that was built for and hosted on the cloud with enterprise grade scale and security. Webinar.net infrastructure is built to handle millions of online presentation attendees from global businesses. This acquisition further enhances our revenue and EBITDA growth in alignment with our medium-term expansion objectives ...read more
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Oct 22, 2022 11:45am
RE:RE:Okay brilliant Earnings Call
Ceo.ca ipa. This site is full of valuable info.
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Comment by
Dragon1
on Oct 21, 2022 10:13am
RE:Okay brilliant Earnings Call
With the amout of insider buying and never any selling you would have to think that the level of confidence from management on the future development of products in the pipeline and acquisitions
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Sep 16, 2022 10:10am
Okay brilliant Earnings Call
TATX is what it is but now IPA has a monster biotech called LENSai. Wow! Read up on this and if you are involved in biotech you know how difficult it is to data-mine and retrieve relevant information.
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Sep 15, 2022 9:37am
WOW! Now in NIH and NIAID - Fauciland
This is MEGA HUGE acknowledgement by NIH in regards to Covid on the efficacy of TATX-03 This NIAID-conducted pseudovirus-based study has reconfirmed the neutralizing activity of TATX-03 against the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 14, 2022 8:34am
New Press Release - NIAID Confirms IPA's PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), announced today that its subsidiary, Talem Therapeutics LLC (“Talem”), has shared positive results of a new study conducted by the National Institute of Allergy and Infectious Disease (NIAID), part of the...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 14, 2022 8:11am
New Press Release - IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023
Structural HYFTs fully indexed and integrated in structure-function workflow LENSai® data management platform successfully launches hyper-scalable solution for partner access, integrating multiple data layers at once Company shares BioStrand case study demonstrating the complete in silico...
read article.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Sep 09, 2022 8:50am
Releasing news on a Wednesday is perfect
Financials are important. We want to see increase in revenue, hopefully double digits. More importantly I would like to know what the cash burn rate is. We know TATX is going into human trials and the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 08, 2022 9:15am
New Press Release - IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022
The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results...
read article.
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Sep 07, 2022 4:58pm
Fingers crossed for record financials.
Financials coming out tomorrow apparently but the sp has been falling like a rock. This may not be good unless you're shorting?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 29, 2022 8:08am
New Press Release - Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope's Efficacy Against SARS-CoV-2 Variants Including BA.5
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), a biotherapeutic research and technology company, today announced the continuing success of PolyTope® TATX-03 antibody combination therapy to neutralize variants of concern of the COVID-19 causative virus...
read article.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 18, 2022 8:54am
RE:stock on fire/ insiders are still loading
We can only hope that the enthuasim for the stock comes back as they continue to prove that Polytope vaccines are Super effective especially when considering Coronavirus mutations. This tech can be
...more
(17)
•••
Vancgatekeeper
X
View Profile
View Bullboard History
Post by
Vancgatekeeper
on Aug 17, 2022 6:37pm
stock on fire/ insiders are still loading
Massive buy under $10, something big is brewing, stock above all MDAs. SEPT TO REMEMBER! Targets 15-25 Sept / 30 plus before 2023
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 17, 2022 3:02pm
RE:IPA insiders are loading and stock closing above all MDAs
Under $8 gone. Load up under $10. I said something was up. Insider buying could mean something big. Potential of this company goning to $100'shr soon is a definitely non-zero. Might be a bit of an
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon